Dr. MEHUL SHAH

Dr. SHREYA SHAH, Dr. DEEKSHA THORAT, Dr. RUHI GUNAY

Abstract

INTRODUCTION: BRVO IS AN CAUSE OF BLINDNESS WOULD LIKE TO DO COMPARATIVE STUDY OF ZYBEV AND AVASTIN ON VISUAL OUTCOME

METHOD: THIS IS A RETROSPECTIVE ANALYSIS OF A COHORT DURING LAST FIVE YEARS AT TERTIARY EYE CARE CENTER. ALL EYES WERE TREATED WITH MEDICAL AND LASER THERAPY. CREATION OF FORMAT AND RETRIVAL OF DATA FROM EMR AND ANALYSED WITH SPSS 22. DESCRIPTIVE AND CROSS TRBULATION METHOD USED FOR ANALYSES. P VALUE <0.05 CONSIDERED STASTICALLY SIGNIFICANT. RESULT: COHORT CONSISTED 155 EYES OF 152 PATIENTS 53.3%,46.7% M:F,MEAN AGE 57.4 YEARS,ON PRESENTATION 33.7 % HAD VISION >6/24 AND 41.1 % HAD VISION < 3/60 . POST TREATMENT VISION ON SUBSEQUENT VISITS >6/24 IN 32.5% AND <3/60 IN 21.8% CASES.WHEN WE COMPARED VISUAL OUTCOME AMONGST AVASTIN AND ZYBEV GROUP WE DID NOT FIND SIGNIFICANT DIFFERENCE. (P=0.54) CONCLUSION: WE DID NOT FIND ANY SIGNIFICANT DIFERENCE BETWEEN AVASTIN AND ZYBEV REATED PATIENTS ON VISUAL OUTCOME FOLLOWING MANAGEMENT OF BRVO [advanced_iframe src="https://view.officeapps.live.com/op/embed.aspx?src=https://aiosproceedings.s3.ap-southeast-1.amazonaws.com/2021/E-Poster/FP314.pptx" width="100%" height="608"]